Los Angeles Capital Management LLC reduced its position in Genpact Limited (NYSE:G - Free Report) by 20.1% in the first quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 423,060 shares of the business services provider's stock after selling 106,412 shares during the quarter. Los Angeles Capital Management LLC owned approximately 0.24% of Genpact worth $21,314,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
A number of other hedge funds also recently bought and sold shares of the business. Vanguard Group Inc. raised its stake in shares of Genpact by 0.4% during the 4th quarter. Vanguard Group Inc. now owns 16,962,496 shares of the business services provider's stock worth $728,539,000 after acquiring an additional 61,376 shares in the last quarter. Franklin Resources Inc. boosted its stake in Genpact by 1.3% during the 4th quarter. Franklin Resources Inc. now owns 4,203,956 shares of the business services provider's stock worth $180,560,000 after purchasing an additional 55,771 shares during the last quarter. Dimensional Fund Advisors LP boosted its stake in Genpact by 5.7% during the 4th quarter. Dimensional Fund Advisors LP now owns 3,848,449 shares of the business services provider's stock worth $165,288,000 after purchasing an additional 208,759 shares during the last quarter. Geode Capital Management LLC boosted its position in shares of Genpact by 3.6% during the 4th quarter. Geode Capital Management LLC now owns 3,825,344 shares of the business services provider's stock valued at $170,175,000 after acquiring an additional 133,938 shares during the last quarter. Finally, JPMorgan Chase & Co. boosted its position in shares of Genpact by 8.7% during the 4th quarter. JPMorgan Chase & Co. now owns 3,400,636 shares of the business services provider's stock valued at $146,057,000 after acquiring an additional 271,295 shares during the last quarter. Hedge funds and other institutional investors own 96.03% of the company's stock.
Insider Buying and Selling
In other Genpact news, Director Nicholas C. Gangestad acquired 2,000 shares of Genpact stock in a transaction on Tuesday, May 13th. The shares were bought at an average price of $43.97 per share, with a total value of $87,940.00. Following the completion of the purchase, the director owned 2,000 shares in the company, valued at $87,940. This trade represents a ∞ increase in their ownership of the stock. The purchase was disclosed in a legal filing with the SEC, which is available through the SEC website. 3.07% of the stock is currently owned by corporate insiders.
Wall Street Analysts Forecast Growth
Several brokerages have commented on G. Wall Street Zen upgraded shares of Genpact from a "buy" rating to a "strong-buy" rating in a research note on Friday, June 6th. Needham & Company LLC reaffirmed a "buy" rating and set a $50.00 price target on shares of Genpact in a report on Monday, June 30th. Mizuho increased their price target on Genpact from $48.00 to $51.00 and gave the stock a "neutral" rating in a report on Tuesday, July 1st. Robert W. Baird reduced their target price on Genpact from $56.00 to $50.00 and set a "neutral" rating for the company in a report on Thursday, May 8th. Finally, Deutsche Bank Aktiengesellschaft assumed coverage on Genpact in a report on Thursday, July 17th. They issued a "hold" rating and a $47.00 target price for the company. Five analysts have rated the stock with a hold rating, three have given a buy rating and one has assigned a strong buy rating to the company's stock. According to MarketBeat.com, the stock currently has a consensus rating of "Moderate Buy" and a consensus price target of $49.75.
Get Our Latest Report on G
Genpact Stock Performance
Shares of NYSE:G traded up $0.94 on Tuesday, hitting $45.84. The company's stock had a trading volume of 925,712 shares, compared to its average volume of 1,422,471. Genpact Limited has a 12 month low of $32.18 and a 12 month high of $56.76. The company has a market capitalization of $8.02 billion, a price-to-earnings ratio of 15.65, a price-to-earnings-growth ratio of 1.73 and a beta of 0.94. The stock's 50-day moving average is $43.78 and its two-hundred day moving average is $47.17. The company has a debt-to-equity ratio of 0.48, a quick ratio of 2.45 and a current ratio of 2.45.
Genpact (NYSE:G - Get Free Report) last announced its earnings results on Wednesday, May 7th. The business services provider reported $0.84 EPS for the quarter, beating the consensus estimate of $0.80 by $0.04. The business had revenue of $1.21 billion during the quarter, compared to the consensus estimate of $1.21 billion. Genpact had a return on equity of 22.35% and a net margin of 10.88%. Genpact's revenue was up 7.4% compared to the same quarter last year. During the same period in the prior year, the business posted $0.73 earnings per share. On average, equities research analysts forecast that Genpact Limited will post 3.21 EPS for the current year.
Genpact Announces Dividend
The firm also recently declared a quarterly dividend, which will be paid on Thursday, September 25th. Shareholders of record on Thursday, September 11th will be given a $0.17 dividend. This represents a $0.68 annualized dividend and a yield of 1.48%. The ex-dividend date of this dividend is Thursday, September 11th. Genpact's dividend payout ratio is currently 23.21%.
About Genpact
(
Free Report)
Genpact Limited provides business process outsourcing and information technology services in India, rest of Asia, North and Latin America, and Europe. It operates through three segments: Financial services; Consumer and Healthcare; and High Tech and Manufacturing. The Financial Services segment offers retail customer onboarding, customer service, collections, card servicing operations, loan and payment operations, commercial loan, equipment and auto loan, mortgage origination, compliance services, reporting and monitoring, and wealth management operations support; financial crime and risk management services; and underwriting support, new business processing, policy administration, claims management, catastrophe modeling and actuarial services, as well as property and casualty claims.
Read More

Before you consider Genpact, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Genpact wasn't on the list.
While Genpact currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking for the next FAANG stock before everyone has heard about it? Enter your email address to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.
Get This Free Report